COST-EFFECTIVENSS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VS. ANGIOTENSIN II RECEPTOR BLOCKERS AS FIRST-LINE TREATMENT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

被引：0
|
作者：
Clark, L. A. [1 ]
Whitmire, S. M. [1 ]
Patton, S. [1 ]
Clark, C. A. [1 ]
Blanchette, C. M. [2 ]
机构：
[1] Univ North Carolina Charlotte, Charlotte, NC USA
[2] Univ N Carolina, Charlotte, NC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK14
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease
    Clark, L. A.
    Whitmire, S.
    Patton, S.
    Clark, C.
    Blanchette, C. M.
    Howden, R.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 715 - 722
  • [2] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
    Tazkarji, Bachir
    Ganeshamoorthy, Ambika
    Auten, Beth
    AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
  • [3] Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease
    Ecder, T
    Edelstein, CL
    Fick-Brosnahan, GM
    Johnson, AM
    Chapman, AB
    Gabow, PA
    Schrier, RW
    AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (02) : 98 - 103
  • [4] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [5] The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease
    van Dijk, MA
    Peters, DJM
    Breuning, MH
    Chang, PC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (09): : 1916 - 1920
  • [6] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [7] Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease
    Ferrari, Paolo
    NEPHROLOGY, 2007, 12 (01) : 81 - 89
  • [8] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
  • [9] NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ASEI) IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Papizh, Svetlana
    Dlin, Vladimir
    Leontieva, Irina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [10] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on accumulation of aliskiren in the kidney
    Rahman, Asadur
    Ohmori, Koji
    Kohno, Masakazu
    Nishiyama, Akira
    JOURNAL OF HYPERTENSION, 2013, 31 (04) : 659 - 660
12345